Printer Friendly PDF Influenza and COVID-19 Outbreak Management in Long-Term Care and Post-Acute Care Facilities Part I – Influenza (Flu) Management and Treatment Options Influenza can be introduced into a long-term care facility by newly admitted residents,...
Printer Friendly PDF From the CMS MDS Manual – N0415: High-Risk Drug Classes: Use and Indication Health-Related Quality of Life: Medications are an integral part of the care provided to residents of nursing homes. They are administered to try to achieve various...
Printer Friendly PDF Vaccines to Prevent Pneumococcal Infection and Disease Pneumococcal disease is common in young children, but older adults are at the greatest risk of seriousillness and death. CDC recommends pneumococcal vaccination for people based on their age...
Moderna mResvia® - Recommendations & Details For patients aged 60 or older, the risk of severe RSV infection and hospitalization can be high—making protection by vaccination that much more important. Respiratory Syncytial Virus (RSV) can cause significant lower...
Printer Friendly PDF Common Fall & Winter Respiratory Illnesses Circulating respiratory viruses such as COVID-19, influenza (flu) and respiratory syncytial virus (RSV) are more common in fall and winter, and can lead to significant illness and disease in the...
Prescriptions written for a beneficiary in a long-term care (LTC)facility will be included in determining complianceEFFECTIVE JANUARY 1ST, 2025 Printer Friendly PDF Is the CMS EPCS Program Voluntary? No. All prescribers who issue controlled substance prescriptions...
Printer Friendly PDF U.S. Population is Aging According to the US Census Bureau, the US population aged 65+ years is expected to nearly double over thenext 30 years, from 43.1 million in 2012 to an estimated 83.7 million in 2050. These demographic advances, however...
Printer Friendly PDF Appropriate Medication Administration Appropriate medication administration pass times are critical to the success of your patients’ medication regimen! In general, routine medication regimens should be administered at consistent times from day to...
Printer Friendly PDF What is Tardive Dyskinesia (TD)? Tardive Dyskinesia (TD) is a drug-induced involuntary movement disorder (DIMD) generally of the tongue, lower face, jaw, and extremities (but sometimes also pharyngeal, diaphragmatic, and trunk muscles) that can...
Printer Friendly PDF From the Centers for Medicare & Medicaid Services (CMS) From CMS: §483.45(g) Labeling of Drugs and Biologicals and §483.45(h) Storage of Drugs and Biologicals: “ensure that all drugs and biologicals used in the facility are labeled in...
Printer Friendly PDF What is Pharmacogenomics (PGx) testing? PGx is rapidly evolving science focused on how an individual’s genes may affect his or her response to medications. While many patients may metabolize a medication appropriately, others may metabolize it too...
Printer Friendly PDF What are GLP-1 Receptor Agonists (GLP-1 RA)? The GLP-1 Receptor Agonist (GLP-1 RA) medications, also referred to as incretin mimetics or GLP-1 analogs, are biochemical variations of naturally occurring GLP-1 altered for enhanced potency and...